Pradeep Sanghvi

Dr. Pradeep Sanghvi rejoined Apotex as Executive Vice President of Global R&D in October 2021 and is responsible for research and development across our businesses.

Dr. Sanghvi is a strategic, transformational, and influential leader with 30 years of experience building high-performance and process-driven R&D organizations. He is a pioneer in many drug delivery platforms, such as ODT and thin films, and has many patents associated with those inventions. He has extensive technical, clinical, commercial, and regulatory knowledge of developing and manufacturing complex generics, 505b2s, and NCEs in various pharmaceutical dosage forms for global markets.

Dr. Sanghvi is actively involved with the American Association for Accessible Medicines (AAM). He holds a PhD in Pharmaceutics from Duquesne University, Pittsburgh.